Cargando…

Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study

PURPOSE: The Oxathiazinane substance class is characterized by a high diversity of chemical structures yet to be fully investigated. Our research group recently proved that the 1.4.5-oxathiazine-4.4-dioxide, known as substance GP-2250, possesses antineoplastic properties as shown on pancreatic carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Majchrzak-Stiller, B., Buchholz, M., Peters, I., Strotmann, J., Möhrke, J., Zelichowski, L., Oehlke, L., Quensel, C., Fein, D., Höhn, P., Müller, T., Uhl, W., Braumann, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374762/
https://www.ncbi.nlm.nih.gov/pubmed/37171614
http://dx.doi.org/10.1007/s00432-023-04799-8
_version_ 1785078846634065920
author Majchrzak-Stiller, B.
Buchholz, M.
Peters, I.
Strotmann, J.
Möhrke, J.
Zelichowski, L.
Oehlke, L.
Quensel, C.
Fein, D.
Höhn, P.
Müller, T.
Uhl, W.
Braumann, C.
author_facet Majchrzak-Stiller, B.
Buchholz, M.
Peters, I.
Strotmann, J.
Möhrke, J.
Zelichowski, L.
Oehlke, L.
Quensel, C.
Fein, D.
Höhn, P.
Müller, T.
Uhl, W.
Braumann, C.
author_sort Majchrzak-Stiller, B.
collection PubMed
description PURPOSE: The Oxathiazinane substance class is characterized by a high diversity of chemical structures yet to be fully investigated. Our research group recently proved that the 1.4.5-oxathiazine-4.4-dioxide, known as substance GP-2250, possesses antineoplastic properties as shown on pancreatic carcinoma. This current study aims to gain insights into the structure and activity relationship of a series of different Oxathiazinanes regarding their antineoplastic activity and the potential correlation with antibacterial activity. We investigated the newly synthesized Oxathiazinane derivatives: 2255, 2256, 2287, 2289, 2293 and 2296 in comparison to GP-2250. METHODS: The antineoplastic effect was evaluated in different cancer entities (breast, skin, pancreas and colon cancer cell lines) by viability, proliferation, and cell migration assays in vitro. Disc diffusion tests were performed on various bacteria strains to examine the antibacterial potential. Additionally, reactive oxygen species (ROS) assays were conducted to investigate mechanistic aspects. RESULTS: The substances GP-2250, 2293, 2289 and 2296 not only showed antineoplastic activity in four different cancer entities but also antibacterial effects, as tested on multiple bacteria strains including MRSA (Methicillin-resistant Staphylococcus aureus). Furthermore, these substances also induced high ROS levels up to 110% in the treated cancer cell lines compared to untreated control cells. These results indicate a correlation between an antineoplastic capacity and antibacterial properties of these derivatives. Both activities appear to be ROS driven. The Oxathiazinane derivatives 2255, 2256 and 2287 lacked both, antineoplastic and antibacterial activity. CONCLUSION: Thus, a comparable structure activity relationship became apparent for both the antineoplastic and antibacterial activity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04799-8.
format Online
Article
Text
id pubmed-10374762
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103747622023-07-29 Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study Majchrzak-Stiller, B. Buchholz, M. Peters, I. Strotmann, J. Möhrke, J. Zelichowski, L. Oehlke, L. Quensel, C. Fein, D. Höhn, P. Müller, T. Uhl, W. Braumann, C. J Cancer Res Clin Oncol Research PURPOSE: The Oxathiazinane substance class is characterized by a high diversity of chemical structures yet to be fully investigated. Our research group recently proved that the 1.4.5-oxathiazine-4.4-dioxide, known as substance GP-2250, possesses antineoplastic properties as shown on pancreatic carcinoma. This current study aims to gain insights into the structure and activity relationship of a series of different Oxathiazinanes regarding their antineoplastic activity and the potential correlation with antibacterial activity. We investigated the newly synthesized Oxathiazinane derivatives: 2255, 2256, 2287, 2289, 2293 and 2296 in comparison to GP-2250. METHODS: The antineoplastic effect was evaluated in different cancer entities (breast, skin, pancreas and colon cancer cell lines) by viability, proliferation, and cell migration assays in vitro. Disc diffusion tests were performed on various bacteria strains to examine the antibacterial potential. Additionally, reactive oxygen species (ROS) assays were conducted to investigate mechanistic aspects. RESULTS: The substances GP-2250, 2293, 2289 and 2296 not only showed antineoplastic activity in four different cancer entities but also antibacterial effects, as tested on multiple bacteria strains including MRSA (Methicillin-resistant Staphylococcus aureus). Furthermore, these substances also induced high ROS levels up to 110% in the treated cancer cell lines compared to untreated control cells. These results indicate a correlation between an antineoplastic capacity and antibacterial properties of these derivatives. Both activities appear to be ROS driven. The Oxathiazinane derivatives 2255, 2256 and 2287 lacked both, antineoplastic and antibacterial activity. CONCLUSION: Thus, a comparable structure activity relationship became apparent for both the antineoplastic and antibacterial activity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04799-8. Springer Berlin Heidelberg 2023-05-12 2023 /pmc/articles/PMC10374762/ /pubmed/37171614 http://dx.doi.org/10.1007/s00432-023-04799-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Majchrzak-Stiller, B.
Buchholz, M.
Peters, I.
Strotmann, J.
Möhrke, J.
Zelichowski, L.
Oehlke, L.
Quensel, C.
Fein, D.
Höhn, P.
Müller, T.
Uhl, W.
Braumann, C.
Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study
title Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study
title_full Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study
title_fullStr Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study
title_full_unstemmed Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study
title_short Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study
title_sort oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374762/
https://www.ncbi.nlm.nih.gov/pubmed/37171614
http://dx.doi.org/10.1007/s00432-023-04799-8
work_keys_str_mv AT majchrzakstillerb oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT buchholzm oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT petersi oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT strotmannj oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT mohrkej oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT zelichowskil oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT oehlkel oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT quenselc oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT feind oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT hohnp oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT mullert oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT uhlw oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy
AT braumannc oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy